Post by Harbour BioMed

Excited to see this landmark partnership between Harbour BioMed and BioMap come to life. Together, we are co-founding MegaStream TechBio — an AI-native complex biologics platform designed to systematically overcome the critical bottlenecks in next-generation therapy development. 🎉 🎉 By integrating Harbour BioMed's proprietary Harbour Mice® platform and decade-deep antibody data with BioMap's 268-billion-parameter life science AI engine (xTrimo), MegaStream will build a self-evolving AI backbone for next-generation complex biologic modalities—including multispecific antibodies, XDC conjugates, in vivo CAR-T, and inhaled/oral biologic. An intelligent dry-wet closed-loop lab is expected to deliver >500% efficiency gains and generate over 5 petabytes of high-quality data within five years. This is what closing the loop from generative design to clinical development looks like. A true step forward for FIC/BIC assets in cardiovascular, renal, CNS, anti-aging, and metabolic diseases. Learn more about this exiting news: https://lnkd.in/g8ewibcc #DrugDiscovery #GenerativeAI #Biologics #Techbio #AIinBiotech